ziprasidone has been researched along with Nausea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D | 1 |
| Caley, CF; Cooper, CK | 1 |
| Bäuml, J; Hirsch, SR; Kissling, W; O'Connor, R; Power, A | 1 |
1 review(s) available for ziprasidone and Nausea
| Article | Year |
|---|---|
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
2 trial(s) available for ziprasidone and Nausea
| Article | Year |
|---|---|
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss | 2007 |
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Nausea; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome; Vomiting | 2002 |